Big Move For Rubius Therapeutics, Inc.

Mon, Dec 14, 2020 at 05:33 PM
Big Move For Rubius Therapeutics, Inc.

Rubius Therapeutics, Inc. (RUBY:NASDAQ) rocketted at $8.73, representing a gain of 36.6%. On Fri 11 Dec 20, RUBY:NASDAQ hit a New 2-Week Intraday Low of $6.21. The stock got featured on our News Catalysts scanner on Fri 11 Dec 20 at 04:59 AM in the 'ACQUISITION' category. From Fri 27 Nov 20, the stock recorded 50.00% Up Days and 63.64% Green Days

The share price of the company has been moving sideways in recent weeks.

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.